CCR5 Antibody

1. Conditioned media or microparticles released from obese omental adipose tissue increased CD16 and CCR5 expression on CD14(+)CD16(-) monocytes and augmented their migratory capacity towards the conditioned media from obese omental adipose tissue, itself. PMID:27677832
2. The block of the protein kinases phosphorylation mediated by staurosporine treatment abrogates the capture of the chemokine receptor CCR5 (CCR5) signalosome into the early endosomes. This suggests the relevant role of phosphorylation events to form steady receptor-beta-arrestin2 complexes, mediated by an ubiquitination of beta-arrestin2 and a durable phosphorylation of ERK1, which are concentrated into the early endoso... PMID:29283386
3. data suggests that the exposure of myeloid cells to Meth in the context of presence of HIV peptides such as Tat, may affect the number of HIV targets by modulating CCR5 expression, through a combination of DA-dependent and-independent mechanisms. PMID:29944719
4. We use CPRC prostate cancer model and demonstrate that endothelial cells secrete large amount of CCL5 and induces autophagy by suppressing AR expression in prostate cancer cell lines. Consequently, elevated autophagy accelerates focal adhesions proteins disassembly and promoted prostate cancer invasion. Inhibition of both CCL5/CCR5 signaling and autophagy significantly reduces metastasis in vivo PMID:30200999
5. Data provides evidence that CCR5 has an essential role in bone-destructive conditions through the functional regulation of osteoclasts. PMID:29263385
6. A critical role for CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma microenvironment. PMID:29089297
7. these findings emphasize the potential involvement of CCR5 signaling in central nervous system inflammation and damage in multiple sclerosis PMID:29729320
8. As patients with and without CCR5Delta32 mutations were similar in terms of histological activity (p = 0.84) and fibrosis stage (p = 0.20) as well as CCR5 tissue expression, the authors reasonably exclude that this CCR5 mutation is significantly involved in the pathogenesis of chronic hepatitis C. PMID:29664712
9. This study demonstrates that, CCR5 promoter polymorphisms correlate with CD4 T cell loss possibly by regulating CD4 T cell apoptosis in HIV patients. PMID:28331180
10. Results suggest that monocytes from Crohn's disease patients in remission produced high levels of CSF-1 that upregulate CCR5 expression. Consequently, monocytes differentiated in these conditions had a characteristic phenotype and lower production of inflammatory cytokines. PMID:28273887
11. The findings provide genetic and epidemiological evidence for an association of UGT1A and CCR5 polymorphisms with hepatitis B virus infection in Chinese Yi and Yao populations. PMID:29239247
12. Authors also demonstrated that Treg migration to the tumor microenvironment is mediated by CCR5, and these cells are promoting tumor growth via inhibition of antitumor cells such as cytotoxic CD8(+) T cells. PMID:28904130
13. These data indicate that cardiac surgery influences the expression of CD162, CD166 and CD195 and that the intensity of the immune system response, displayed as the change in the CD162, CD166, CD195 expression, varies, depending on the surgical technique used. PMID:27625334
14. the interaction between CCR5 and its ligands promotes the proliferation of CCR5(+) polymorphonuclear-myeloid-derived suppressor cells at the bone marrow PMID:29166611
15. CCR5Delta32 allele is not associated with susceptibility to HIV-1 infection in Iranian population. PMID:29209099
16. engineered CCR5Delta32/Delta32 mutations endowed CD4+ U87 cells with resistance against HIV1 infection; this sitespecific, sizecontrolled and homozygous DNA deletion technique was able to induce precise genomic editing PMID:29115572
17. KLF5-regulating cancer-associated fibroblasts affect gastric cancer cells progression by CCL5 secretion and activation of CCR5. PMID:28934010
18. CCR5Delta32 mutation is not associated with acute graft-versus-host disease. PMID:28862353
19. CCR5 is involved but also to generate new antidody-based therapeutics. PMID:28008933
20. These results confirm the protective role of CCR5Delta32, and extend it to the long-term survival in a large cohort of HIV-infected patients. Beyond its antiviral effect, CCR5Delta32 enhanced the long-term survival of patients on cART. PMID:29221798
21. This study showed that individuals with the CCR5/CCR5 genotype and simultaneously the CCR5-59029 AA or AG genotypes have a greater risk of developing ocular toxoplasmosis, which may be associated with a strong and persistent inflammatory response in ocular tissue. PMID:29221851
22. the protective CCR5-Delta32 allele appears to be rarely present in Saudi Arabia. PMID:28731615
23. these data highlight the important role of CCR5 in the onset of acute coronary syndrome and suggest this receptor as a marker of cardiovascular risk PMID:28276569
24. we observed an overall protective effect associated to the presence of the CCR5Delta32 allele against RA susceptibility that was evidenced in cities with a lower African genetic component. Our results highlight the importance of assessing the influence of CCR5 under different genetic backgrounds. PMID:28082621
25. results suggest that the CCR5 gene and its product might play a role in the pathogenesis of Crimean-Congo hemorrhagic fever infection PMID:28547880
26. the interplay between chemokine receptor CCR5 expression, cancer stem cells, and hypoxia PMID:28693495
27. genetic association studies in population in Poland: Data suggest that CCR5-delta32 gene polymorphism is associated with type 1 diabetes (T1D) and increases risk of celiac disease and autoimmune thyroid disorders in patients with T1D; risk of celiac disease or autoimmune thyroiditis in carriers of 32-bp deletion is more than threefold higher than for non-carriers. PMID:27894748
28. differential distribution of the viral reservoir compartment in CCR5((WT/Delta32)) patients with perinatal HIV infection PMID:28042001
29. The donor CCR5 -2086A/A genotype was associated with a lower incidence of grades 3-4 acute GVHD, which did not improve the survival outcomes. These findings suggest that the recipient CCR5 -2086A/A genotype affects the induction of the graft-versus-tumor effect without augmenting the development of GVHD. PMID:28487238
30. searched for the relationship between single nucleotide polymorphism in the promoter region of the CD209, IL-10, IL-28 and 32 base pair deletion in CCR5 coding region (Delta 32) with the human predisposition to development of various clinical presentations of tick-borne encephalitis PMID:28894041
31. Deficiency of CCR5 exacerbates alcoholic fatty liver disease by hepatic inflammation induced by pro-inflammatory cytokines and chemokines and oxidative stress. PMID:27859576
32. rs1800024 polymorphism significantly associated with occurrence risk of psoriasis vulgaris in Chinese population PMID:29145242
33. CCR5-tropic HIV infection is limited to more differentiated progenitor cells with life spans that are less well understood. PMID:28732051
34. Data provide evidence that CCR5 activation mediates CCL5 enhances the proliferation and the invasive capacity of human breast cancer cell lines. PMID:27335323
35. CCR5-Delta32 polymorphism is associated with type 1 diabetes. PMID:27619405
36. CCR52 genetic variants were not associated with risk of atherosclerotic coronary heart disease and glucometabolic traits PMID:27013693
37. No sickle cell disease patients presented CCR5Delta32 deletion. PMID:28671257
38. this review discusses the role of CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma PMID:28382399
39. CCR5 is highly expressed in active inflammatory bowel disease, and it has positive correlation with lymphocyte grade and negative correlation with expression of beta-arrestin2. PMID:28140695
40. this study shows that the dominant signature of resistance to HIV infection in this cohort of exposed but uninfected individuals was lower T-cell CCR5 expression PMID:28398593
41. the level of IFNAR1, IFNAR2, and CCR5 mRNA expression was found to be significantly lower in the responders than nonresponders.Our results highlighted the significance of IFNAR and CCR5 genes in multiple sclerosis risk and the response to IFN-b therapy. PMID:27346865
42. Env regions that respond to CCR5 binding was located in the gp120 alpha1 helix and in the gp41 HR1 heptad repeat and membrane-proximal external region. PMID:28521215
43. A frameshift mutation in CCR5 was associated, but not significantly, with sporadic inclusion body myositis. PMID:28086002
44. study revealed that while HIV-1 gp120 and Staph aureus LukED both target CCR5, they bind to different regions of the receptor, highlighting the divergence of the pathogens PMID:27965453
45. Genetic variation of CCR5 gene demonstrates a possible association with hypertension, diabetes mellitus and atherosclerosis comorbidity in patient treated with hemodialysis. PMID:27118566
46. Findings indicate the importance of chemokine (CC motif) ligand 5 (CCL5) genetic variability and CCL5-CCR5 (CC chemokine receptor 5) axis on the susceptibility to HCV. PMID:27304910
47. The transferred nuclear Overhauser effect (TRNOE) crosspeaks in the ternary complex were assigned to the specific Tyr protons in the human C-C chemokine receptor 5 (CCR5) chemokine receptor peptide and to methyl protons, predominantly of isoleucine residues, and also of leucine and/or valine residues of HIV-1 gp120 envelope protein. PMID:27701820
48. Intermolecular interactions of RANTES with its receptor CCR5 have been reported based on NMR spectroscopy measurements. PMID:28052516
49. Binding of J113863 to CCR2 or CCR5 also induced the recruitment of beta-arrestin 2, whereas UCB35625 did not. UCB35625 induced the chemotaxis of L1.2 cells expressing CCR2 or CCR5. In contrast, J113863 induced the migration of L1.2-CCR2 cells but antagonized the chemokine-induced migration of L1.2-CCR5 cells. PMID:27895119
50. The higher frequency of CCR5 wild-type allele among leishmaniasis patients may suggest an increased risk of HIV infection and also support its facilitative role in Leishmania infection PMID:26970327

Show More

Hide All

HGNC: 1606

UNIGENE: Hs.450802

KEGG: hsa:1234

STRING: 9606.ENSP00000292303

OMIM: 601373